Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemiaCarsten Müller‐Tidow, Christian Thiede, Anja Koschmieder et al.|Leukemia|2015Cited by 49
Intermediate-dose cytarabine plus mitoxantrone versus standard-dose cytarabine plus daunorubicin for acute myeloid leukemia in elderly patientsChristoph Röllig, Ulrich S. Schuler, Michael Krämer et al.|Annals of Oncology|2018Cited by 37